相关实验视频
Updated: May 4, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
22.5K
模拟针对口病的疫苗接种策略
M J Keeling1, M E J Woolhouse, R M May
1Department of Biological Science & Mathematics Institute, University of Warwick, Gibbet Hill Road, Coventry, CV4 7AL, UK. m.j.keeling@warwick.ac.uk
Nature
|January 1, 2003
概括
接种疫苗可以控制牲畜中的口病 (FMD) 流行病. 预防性疫苗接种和有针对性的反应性策略,包括预测性疫苗接种是有效的.
科学领域:
- 兽医流行病学 兽医流行病学
- 传染病建模传染病建模
- 动物健康经济学 动物健康经济学
背景情况:
- 疫苗接种是控制人类和动物传染病的关键工具.
- 疫苗对控制牲畜口病 (FMD) 流行病的有效性仍然是争论的主题.
- 需要有效的策略来减轻口热爆发的影响.
研究的目的:
- 评估不同疫苗接种策略的有效性,以控制家畜口热流行病.
- 为了比较预防性疫苗接种与反应性疫苗接种和杀策略.
- 探索"预测性"疫苗接种在控制口热疫情中的潜力.
主要方法:
- 开发和应用一个基于个别农场的流行病学模型.
- 在疫情爆发之前,模拟国家预防性疫苗接种活动.
- 在流行病期间对反应性疫苗接种和除策略的建模,包括针对空间传播的预测性疫苗接种.
主要成果:
- 大规模预防性疫苗接种显著降低了主要口热流行病的风险.
- 针对高风险农场提高了疫苗接种活动的效率.
- 如果有足够的资源,反应性疫苗接种和杀的组合可以控制正在进行的流行病.
- "预测性"疫苗接种有效地减少了口热流行病的长期持续性.
结论:
- 疫苗接种,特别是当战略性地应用时,是控制牲畜口热流行病的可行工具.
- 预防性和向性反应性疫苗接种策略的组合提供了对口病控制的最强有力的方法.
- 这些发现对在空间结构化人口中管理传染病具有更广泛的意义.
相关概念视频
01:51Vaccinations
44.1K
Overview
44.1K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97